Dr med. Kottmann

The double-blind randomised, placebo-controlled, clinical prospective study on pain reduction in patients with cervical spine syndrome is probably the most significant proof that we are literally working with waves of success. The 52 test subjects in the study received ten treatments with a standardised Compact Program. Neither the patient nor the doctor conducting the trial knew whether an effective device or a placebo was being used. 

This study showed significant improvements in clinical parameters for neck pain, headache, back pain and tension using the Rayocomp bioresonance device. The participants in the study also confirmed an improvement in physical performance. However, no improvement was observed with placebo treatment. 

This scientific study now provides proof of the safe and effective use of Bioresonance according to Paul Schmidt for both patient and practitioner. The results of the study confirm what our users have been telling us for decades: Bioresonance according to Paul Schmidt alleviates complaints and helps patients to regain a sense of well-being.